drugset / Trial / NCT05459519
Effects of Dengzhanxixin Capsule on Platelet Function in Individuals at High Risk for Cardiovascular Disease
Unknown
165 enrolled
China National Center for Cardiovascular Diseases
Chinese Academy of Medical Sciences, Fuwai Hospital · collab
RandomizedParallel-groupDouble-blindPrevention
Summary
The main objective of this clinical trial is to evaluate whether the antiplatelet efficacy of the Dengzhanxixin capsule is better than that of placebo in individuals at high-risk for atherosclerotic cardiovascular disease (ASCVD).
Timeline
- Start
- 2022-07-20
- Primary completion
- 2023-12-31
- Completion
- 2023-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dengzhanxixin Capsule | Traditional medicine (herbal / TCM) | 0.54 g | — |
| Subject | Dengzhanxixin Capsule | Traditional medicine (herbal / TCM) | 0.72 g | — |